DCI Partners is a Tokyo based venture capital firm investing in biotech startups in Japan and Taiwan. Established on May 20, 2014, the company has a share capital of 50 million Japanese yen with a fund size of 11.6 billion yen. It focuses its investments in companies that specialize in life sciences and therapeutics. Along with the funds, the company provides expertise in clinical development, intellectual property, and business development. The firm has an extensive network of academics, bio-techs, and pharma in Japan and Taiwan to support its portfolio companies.
Documentaries, videos and podcasts
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.